In patients with early-stage BC treated with upfront surgery, the discordance rate in HR status between core needle biopsies (CNB) and paired surgical samples was reported to be low overall, i.e., 1.8% for ERα and 15% for PgR [91]. The gene discussed is ESR1; the disease is breast cancer.